Rosemary E. Gale
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 68 publications
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences risk of acute myeloid leukemia.
Journal: Blood
Published: August 19, 2025
Common variation at 1q23.3, 2p23.3, 2q33.3, and 2p21 influences the risk of acute myeloid leukemia.
Journal: Blood
Published: August 19, 2025
Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients.
Journal: Journal of hematology & oncology
Published: May 19, 2024
Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML.
Journal: Blood
Published: February 27, 2024
Prognostic impact of CEBPA mutational subgroups in adult AML.
Journal: Leukemia
Published: October 30, 2023
Author Correction: Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Journal: Nature communications
Published: January 05, 2022
Correction: PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kB, MAPkinase and p53 pathways.
Journal: Leukemia
Published: October 16, 2021
Therapy for isocitrate dehydrogenase 2 (IDH2)R172 -mutant acute myeloid leukaemia.
Journal: British journal of haematology
Published: September 05, 2021
Prognostic value of Oncogenetic mutations in pediatric T Acute Lymphoblastic Leukemia: a comparison of UKALL2003 and FRALLE2000T protocols.
Journal: Leukemia
Published: September 28, 2020
The clinical impact of mutant DNMT3A R882 variant allele frequency in acute myeloid leukaemia.
Journal: British journal of haematology
Published: February 01, 2020
Genome-wide association study identifies susceptibility loci for acute myeloid leukemia.
Journal: Nature communications
Published: January 30, 2020
Last Updated: 09/26/2026